Cleveland Clinic Breast Cancer Update Review of Breast Cancer Symposia 2025
Cleveland Clinic Breast Cancer Update Review of Breast Cancer Symposia 2025 Original price was: $350.00.Current price is: $89.00.
Back to products
Harvard Testosterone Therapy and Sexual Dysfunction 2026
Harvard Testosterone Therapy and Sexual Dysfunction 2026 Original price was: $1,475.00.Current price is: $149.00.

USCAP 2025 Contemporary Issues in Breast Pathology

Original price was: $2,200.00.Current price is: $149.00.

★★★★★
4.9
(91 reviews)

💰 You save $2,051 — offer ends soon

🔬 Expert-led review of benign, in situ and malignant breast lesions — intraductal proliferations, LCIS, papillary and fibroepithelial lesions, spindle cell and vascular tumors, triple-negative and HER2-low cancers, immunohistochemistry, molecular testing, digital slides and AI. 37 videos + 28 PDFs · 17.33 GB.


54 viewing now
🔥 Bestseller

21 sold in last 24h

Limited access at this price — secure your spot before the next price increase

Secure payment via

PayPal American Express
🔒
Secure Checkout
↩️
30-Day Refund
♾️
Lifetime Access

Instant Download
Category:
Description

🔬 USCAP · Breast Pathology · 2025 Edition

Contemporary Issues in
Breast Pathology 2025

United States & Canadian Academy of Pathology · Released July 28, 2025

37 Video Lectures + 28 PDFs · 17.33 GB — Instant Digital Access

⚡ INSTANT DIGITAL ACCESS

Includes: 37 Video Lectures + 28 PDF Resources | Total Size: 17.33 GB | Google Drive delivery

37
Video Lectures

28
PDF Resources

29
Expert Sessions

17.33
GB Total Size

📚 Course Overview

USCAP 2025 Contemporary Issues in Breast Pathology provides a comprehensive review and update of the pathologic diagnosis and clinical significance of benign, in situ and malignant breast lesions encountered in surgical specimens and core needle biopsies.

The program emphasizes difficult differential diagnostic problems and the most current uses of adjunctive immunohistochemical and molecular studies — how these tools support lesion classification, improve diagnostic accuracy, and help guide patient management.

The curriculum combines expert lectures with digital slide sessions covering atypical proliferations, fibroepithelial lesions, spindle cell and vascular lesions, triple-negative neoplasms, mucinous lesions, ER-positive cancers and unusual breast tumors.

Strengthen diagnostic confidence across the full spectrum of breast pathology — from routine core biopsies to the cases that stop you at the microscope.

🎯 Why Review This Program

A practical update for challenging breast pathology cases

01
Diagnostic Precision
Review criteria for benign, atypical, in situ, invasive and uncommon breast lesions.

02
Digital Slide Practice
Reinforce pattern recognition through guided digital slide sessions across difficult entities.

03
Ancillary Testing
Understand the uses — and the limitations — of immunohistochemical and molecular studies.

04
Current Classification
Review HER2-low, ER-low, triple-negative and special-type breast cancers.

🔍 Diagnostic Coverage

Key areas across contemporary breast pathology

Proliferative Lesions
Intraductal & Lobular
Intraductal proliferations, atypia, LCIS, papillary lesions and apocrine proliferations.

Core Biopsy
Needle Biopsy Challenges
Contemporary diagnostic issues in core needle biopsies and limited tissue samples.

Mesenchymal Lesions
Fibroepithelial, Spindle & Vascular
Challenging fibroepithelial tumors, spindle cell lesions and vascular neoplasms.

Cancer Subtypes
TNBC, HER2-Low & ER-Low
Classic and special-type triple-negative cancers, HER2-low disease and ER-low tumors.

Ancillary Studies
Molecular & Predictive Testing
Molecular testing, prognostic assays, predictive markers and their diagnostic limitations.

Emerging Practice
Digital Pathology & AI
Digital slide interpretation and emerging applications of artificial intelligence.

✅ Learning Outcomes

A

Describe the diagnostic criteria and clinical significance of benign, in situ and malignant breast lesions in surgical specimens and core needle biopsies.

B

Discuss differential diagnostic problems and build a more focused approach to difficult cases.

C

Apply immunohistochemical and molecular tests appropriately while recognizing their uses and limitations.

D

Discuss prognostic and predictive assays used in patients with breast cancer.

E

Improve interpretation of post-neoadjuvant specimens, lymph nodes, unusual lesions and contemporary breast cancer subtypes.

👩‍🔬 Expert Faculty

Learn from recognized breast pathology specialists

Laura Collins, MD
COURSE CO-DIRECTOR
Core biopsies, glandular lesions, TNBC, margins

Stuart Schnitt, MD
COURSE CO-DIRECTOR
LCIS, HER2-low and ER-low cancers, TNBC, AI

Ashley Cimino-Mathews, MD
Breast lesions, molecular testing, TNBC, immune microenvironment

Cecily Quinn, MD, FRCPath
Atypical proliferations, inflammatory, apocrine and spindle lesions

Edi Brogi, MD, PhD
Papillary lesions, unusual cases, invasive cancers, lymph nodes

Puay Hoon Tan, MD
Fibroepithelial, mucinous, neuroendocrine and myoepithelial lesions

Gregory Bean, MD, PhD
Vascular lesions, neoadjuvant specimens, uncommon invasive cancers

🔬 Primary Audience

Designed for pathologists managing breast specimens

Practicing pathologists
Academic pathologists
Community pathologists
Surgical pathologists
Breast pathology specialists
Residents & fellows

📋 Complete Curriculum

29 expert-led sessions and digital slide reviews

🧫 Part 1 — Proliferative & Papillary Lesions (Sessions 1–10)
01. Intraductal Proliferative Lesions — Ashley Cimino-Mathews, MD
02. Update on Classification and Management of LCIS — Stuart Schnitt, MD
03. Contemporary Issues in Breast Core Needle Biopsies — Laura Collins, MD
04. Digital Slides: Small Glandular Proliferations — Laura Collins, MD
05. Digital Slides: Atypical Intraductal Proliferations — Cecily Quinn, MD
06. Inflammatory and Reactive Lesions — Cecily Quinn, MD
07. Papillary Proliferations — Edi Brogi, MD, PhD
08. Challenging Fibroepithelial Lesions — Puay Hoon Tan, MD
09. Apocrine Proliferations — Cecily Quinn, MD
10. Digital Slides: Fibroepithelial Lesions — Puay Hoon Tan, MD

🔬 Part 2 — Mesenchymal Lesions & Breast Cancer Subtypes (Sessions 11–19)
11. Spindle Cell Lesions — Cecily Quinn, MD
12. Vascular Lesions — Gregory Bean, MD, PhD
13. Applications of Molecular Testing in Breast Cancer — Ashley Cimino-Mathews, MD
14. Classic TNBC, TILs and the Immune Microenvironment — Ashley Cimino-Mathews, MD
15. Special Type Triple Negative Breast Cancers — Laura Collins, MD
16. HER2-Low and ER-Low Breast Cancers — Stuart Schnitt, MD
17. Pathologic Evaluation After Neoadjuvant Therapy — Gregory Bean, MD, PhD
18. Digital Slides: Spindle Cell and Vascular Lesions — Gregory Bean, MD, PhD
19. Digital Slides: Triple Negative Breast Neoplasms — Stuart Schnitt, MD

🧬 Part 3 — Uncommon Lesions, Lymph Nodes & AI (Sessions 20–29)
20. Mucinous and Neuroendocrine Lesions — Puay Hoon Tan, MD
21. Specimen Handling and Margin Evaluation — Laura Collins, MD
22. Epithelial-Myoepithelial Proliferations — Puay Hoon Tan, MD
23. Uncommon Clinical Scenarios — Edi Brogi, MD, PhD
24. Digital Slides: Mucinous Lesions and ER+ Breast Cancers — Ashley Cimino-Mathews, MD
25. Digital Slides: Unusual Breast Lesions — Edi Brogi, MD, PhD
26. Uncommon Types of Invasive Breast Cancers — Gregory Bean, MD, PhD
27. Contemporary Lymph Node Evaluation — Edi Brogi, MD, PhD
28. Applications of AI to Breast Pathology — Stuart Schnitt, MD
29. Panel Discussion and Q&A — Expert faculty

📦 Delivery & Access

🎬
Course Files
37 video lectures and 28 PDF resources, 17.33 GB total.

📁
Google Drive
Delivered through a direct Google Drive link — no physical shipping.

📱
Flexible Review
Review on compatible computers, tablets and mobile devices.

ℹ️
Course Files Only
CME credits, official registration, certification and institutional enrollment are not included.

💬 What Pathologists Say

“The digital slide sessions are the strongest part. Genuine pattern recognition practice, not just lecture slides.”

Dr. Helena K. — Surgical Pathologist

“The HER2-low and ER-low content is exactly the update I needed. Clear on where the thresholds actually sit.”

Dr. Tomás R. — Breast Pathology Fellow

“Excellent coverage of fibroepithelial and spindle cell lesions — the cases that cost me the most sign-out time.”

Dr. Amara O. — Community Pathologist

Limited Promotional Price
$2,200
$149

Complete breast pathology program — 37 video lectures + 28 PDFs · 17.33 GB. Instant access, lifetime learning.

Get Immediate Access

🔒
Secure Checkout

📥
Instant Download

♾️
Lifetime Access

📱
All Devices

💬 Need Help or Have Questions?

Our support team is available around the clock — email us at support@medicalosa.com and we’ll get back to you quickly.